Cite
HARVARD Citation
Zhou, D. et al. (2021). Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study. European journal of cancer. pp. 525-526. [Online].